Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Juvenile Dermatomyositis. Strongest funded area: Basic Science. Largest gap: Clinical Research.
Clinical ResearchTrials Active, No NIH Grants
11 clinical trials registered but no NIH-funded clinical or translational research grants found for juvenile dermatomyositis. Trials may be industry-sponsored or funded through non-NIH sources.
Clinical ResearchPublished, Not NIH-Funded
20 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for juvenile dermatomyositis. Existing research activity suggests this may be a viable area for grant applications.
Translational / Drug DevelopmentPublished, Not NIH-Funded
9 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for juvenile dermatomyositis. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(1 grant)
These grants mention Juvenile Dermatomyositis as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(1)
OtherR01Completed
A nonpsychoactive cannabinoid receptor-2 agonist to treat itch and inflammation in dermatomyositis
WERTH, VICTORIA·UNIVERSITY OF PENNSYLVANIA·PHILADELPHIA, PA
